U.S. equity markets finished the week in the red despite some positive data and strong corporate earnings. NVIDIA reported strong revenue and upbeat guidance, yet the stock fell ~3% and pulled broader markets down. Markets were weighed down by concerns over elevated valuations and scepticism about whether the recent surge in AI-related spending will be sufficiently profitable.
European equities fell amid worries about inflated AI valuations and U.S. rate uncertainty. On the economic data front, the services PMI rose slightly to an 18-month high of 53.1. However, the gauge for manufacturing fell to 49.7 from 50.0. UK inflation fell to 3.6% in October, signalling the possibility of further rate cuts if disinflation continues.
Japanese equities dropped for the week, led by heavy losses in AI-related tech firms. Meanwhile, Chinese stock markets fell amid concerns over high valuations in AI stocks. Japan announced a ¥21.3 trillion ($135 billion USD) stimulus package to boost its economy, while China is contemplating new measures to support its struggling property market to prevent financial instability.
Most anticipated earnings report of the quarter, chipmaker NVIDIA, the largest company by capitalization in the S&P 500, reported record revenue last week that exceeded analysts’ expectations, driven by strong demand for its AI chips. The company also provided a healthy revenue forecast for the fourth quarter that surpassed consensus estimates. The market initially reacted favourably to the news at open, but sentiment turned negative later during the day, and NVIDIA finished 3% lower and pulled the major benchmarks down with it.
| Index | Current Price | 1 Week Return % |
|---|---|---|
| S&P 500 | 6,602.99 | -1.95% |
| DJIA | 46,245.41 | -1.91% |
| Nasdaq | 22,273.08 | -2.74% |
| Nikkei 225 | 48,625.88 | -3.15% |
| FTSE 100 | 9,539.71 | -1.64% |
| Shanghai Composite | 3,834.89 | -3.90% |
| Sensex | 85,231.92 | 0.79% |
| ADX Index | 9,885.12 | -0.33% |
| Gold | 4,079.50 | -0.36% |
| Brent Oil (Brent) | 62.56 | -2.84% |
While we remain constructive on the broader market environment, this is an opportune time to rebalance portfolios to better align with long-term strategic objectives. Alongside maintaining exposure to technology and AI-related opportunities, we suggest increasing allocations to U.S. large- and mid-cap equities, particularly within sectors such as health care and industrials. Adding selective emerging-market exposure can further enhance diversification, resilience, and long-term growth potential.
Let our investment specialists help you tailor your portfolio for what’s ahead.
Disclaimer
This commentary is provided for informational purposes only and does not constitute investment advice. For detailed insights, contact our investment team.